164 related articles for article (PubMed ID: 16607285)
1. Hepatocellular carcinoma in Txnip-deficient mice.
Sheth SS; Bodnar JS; Ghazalpour A; Thipphavong CK; Tsutsumi S; Tward AD; Demant P; Kodama T; Aburatani H; Lusis AJ
Oncogene; 2006 Jun; 25(25):3528-36. PubMed ID: 16607285
[TBL] [Abstract][Full Text] [Related]
2. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.
Wang Z; Rong YP; Malone MH; Davis MC; Zhong F; Distelhorst CW
Oncogene; 2006 Mar; 25(13):1903-13. PubMed ID: 16301999
[TBL] [Abstract][Full Text] [Related]
4. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
5. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
[TBL] [Abstract][Full Text] [Related]
6. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells.
Pang ST; Hsieh WC; Chuang CK; Chao CH; Weng WH; Juang HH
J Mol Endocrinol; 2009 Mar; 42(3):205-14. PubMed ID: 19052253
[TBL] [Abstract][Full Text] [Related]
8. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
10. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
11. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
12. Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73.
Tannapfel A; John K; Mise N; Schmidt A; Buhlmann S; Ibrahim SM; Pützer BM
Carcinogenesis; 2008 Jan; 29(1):211-8. PubMed ID: 17984115
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
[TBL] [Abstract][Full Text] [Related]
14. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
[TBL] [Abstract][Full Text] [Related]
15. Gamma-ray induced hepatocarcinogenesis in p53-deficient mice.
Kaizu H; Cho D; Matsuki A; Ohkoshi S; Nomoto M; Asakura H
Anticancer Res; 2000; 20(3A):1545-9. PubMed ID: 10928068
[TBL] [Abstract][Full Text] [Related]
16. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
18. The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients.
Erkeland SJ; Palande KK; Valkhof M; Gits J; Danen-van Oorschot A; Touw IP
Leuk Res; 2009 Oct; 33(10):1367-71. PubMed ID: 19327827
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.
Yoshioka J; Imahashi K; Gabel SA; Chutkow WA; Burds AA; Gannon J; Schulze PC; MacGillivray C; London RE; Murphy E; Lee RT
Circ Res; 2007 Dec; 101(12):1328-38. PubMed ID: 17916779
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
